8-K: Reviv3 Procare Company to Uplist to NYSE American, Rebrands as AXIL Brands, Inc.

Sentiment:

Uplisting and Rebranding Announcement


Reviv3 Procare Company announces its upcoming uplisting to the NYSE American exchange and rebranding as AXIL Brands, Inc., effective February 14, 2024, focusing on the global hearing enhancement and protection market.

Summary

  • Reviv3 Procare Company is set to uplist its common stock to the NYSE American exchange.
  • The company will rebrand as AXIL Brands, Inc., effective February 14, 2024.
  • The new ticker symbol on the NYSE American will be AXIL.
  • The company's focus is on the global hearing enhancement and protection devices market through its AXIL brand, alongside its Reviv3 hair and skin care products.
  • The uplisting and rebranding are aimed at diversifying the stockholder base, improving liquidity, and increasing stockholder value.

Sentiment

Score: 8

Explanation: The announcement is highly positive, reflecting a major step forward for the company with the uplisting and strategic rebranding.

Positives

  • Uplisting to the NYSE American is a significant milestone achievement.
  • The NYSE American listing is expected to diversify the stockholder base.
  • Listing on a major exchange like the NYSE American will likely provide greater liquidity for stockholders.
  • The rebranding to AXIL Brands, Inc. aligns the company name with its core product focus on hearing enhancement and protection.
  • The company believes the name change will allow it to capitalize on the recognition of the AXIL brand.

Negatives

  • The document does not explicitly state any negative aspects of the uplisting or rebranding.

Risks

  • There is a risk that the company may not meet all the listing requirements at the time of listing.
  • Actual results may differ materially from forward-looking statements due to various factors beyond the company's control.
  • The forward-looking statements are not guarantees of future performance and involve uncertainties and assumptions that are difficult to predict.

Future Outlook

The company expects the uplisting and rebranding to enhance its market position, improve stockholder liquidity, and increase stockholder value by focusing on the global hearing enhancement and protection market.

Management Comments

  • We are excited to execute on another two major steps in our corporate rebranding with the milestone achievement of being listed on the NYSE American and the official change of our company's name to AXIL Brands, Inc.
  • We believe that listing on the NYSE American Exchange will help diversify our stockholder base, provide greater liquidity for our stockholders, and improve our ability to increase stockholder value.
  • Renaming our company to AXIL Brands, Inc. reflects our focus on the global hearing enhancement and protection devices market and we believe will allow us to capitalize on the recognition of the AXIL brand in the hearing protection and enhancement market.

Industry Context

This announcement positions AXIL Brands, Inc. more prominently within the growing market for hearing enhancement and protection devices, a sector seeing increased consumer awareness and demand.

Comparison to Industry Standards

  • The document does not provide specific details on financial performance or operational metrics that can be directly compared to industry standards or competitors.
  • However, the uplisting to the NYSE American suggests that the company is striving to meet the standards of larger, publicly traded companies in terms of corporate governance, transparency, and market visibility.
  • Comparable companies in the hearing protection and enhancement market include Eargo, Inc. (EAR) and Intricon Corporation (IIN).
  • Eargo, Inc. has experienced significant revenue growth in recent years, driven by strong demand for its direct-to-consumer hearing aids.
  • Intricon Corporation, a manufacturer of micro-medical components, has also seen growth in its hearing health segment.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Class I DirectorN/ANancy HundtFebruary 14, 2024Classified Board Amendment
Class II DirectorN/APeter DunneFebruary 14, 2024Classified Board Amendment
Class II DirectorN/AManu OhriFebruary 14, 2024Classified Board Amendment
Class III DirectorN/AJeff ToghraieFebruary 14, 2024Classified Board Amendment
Class III DirectorN/AJeff BrownFebruary 14, 2024Classified Board Amendment

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Name ChangeThe company's name will change from Reviv3 Procare Company to AXIL Brands, Inc.February 14, 2024Reflects the company's focus on the AXIL brand and the hearing enhancement and protection market.
Classified BoardThe Board of Directors will be divided into three classes: Class I, Class II, and Class III, with staggered terms.February 14, 2024May enhance board stability and continuity.
Board Authority over BylawsThe Board will have the authority to make, repeal, alter, amend, or rescind any or all of the company's Bylaws.February 14, 2024Increases the Board's flexibility in managing corporate governance.
Advance Notice for Stockholder Nominations and ProposalsStockholders must provide advance notice to the company for nominations of directors and proposals for matters they intend to bring up at a stockholder meeting.February 14, 2024Provides the company with more time to prepare for and respond to stockholder proposals.

Stakeholder Impact

  • Shareholders: Potential for increased liquidity and stockholder value due to the uplisting and rebranding.
  • Employees: No immediate impact mentioned, but the changes could positively affect the company's growth and stability.
  • Customers: Continued access to AXIL and Reviv3 products, with potential benefits from the company's increased market presence.
  • Suppliers: No immediate impact mentioned.
  • Creditors: No immediate impact mentioned.
  • NYSE American: The exchange will add a new listing to its roster of companies.

Next Steps

  • Commence trading on the NYSE American under the ticker symbol AXIL on February 14, 2024.
  • Terminate trading of the Common Stock on the OTCQB.
  • Continue marketing and selling hearing enhancement and protection products under the AXIL brand and hair and skin care products under the Reviv3 Procare brand.

Key Dates

DateDescription
June 9, 2015Filing of the Corporations Amended and Restated Certificate of Incorporation
June 13, 2022Filing of a Certificate of Amendment
December 4, 2023Schedule 14C filed with the Securities and Exchange Commission
January 12, 2024Filing of a Certificate of Amendment
February 9, 2024Announcement of expected listing on NYSE American and corporate name change
February 12, 2024Filing of a Certificate of Amendment to the Companys Amended and Restated Certificate of Incorporation with the Delaware Secretary of State
February 13, 2024Last day of trading on the OTCQB
February 14, 2024Effective date of name change to AXIL Brands, Inc., ticker symbol change to AXIL, and expected start of trading on the NYSE American

Keywords

hearing protection, hearing enhancement, ear plugs, earmuffs, ear buds, consumer products, e-commerce, NYSE American, uplisting, rebranding, stockholder value, liquidity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.